Who / What
Herd immunity, also known as herd effect, community immunity, population immunity, or mass immunity, is a form of indirect protection that applies only to contagious diseases. It occurs when a sufficient percentage of a population has become immune—either through previous infection or vaccination—such that the pathogen cannot maintain transmission within the community. When herd immunity is reached, disease incidence drops sharply, and the disease may gradually disappear or be permanently reduced to zero.
Background & History
The concept of herd immunity has long been recognized in epidemiology, although its precise calculation and application have evolved with advances in virology and public health. Historically, immunity thresholds were identified for diseases such as smallpox and measles as vaccination campaigns progressed. Key milestones include the development of the first effective vaccines and the subsequent adoption of herd‑immunity thresholds in public‑health policy. More recent work has refined mathematical models to predict vulnerability windows for emerging infections.
Why Notable
Herd immunity is central to controlling outbreaks because it protects not only those who are vaccinated but also the vulnerable who cannot be immunized. By interrupting the chain of transmission, it reduces healthcare burden and can lead to eradication (e.g., smallpox). The concept informs vaccine development strategies, mass‑vaccination campaigns, and pandemic preparedness plans worldwide.
In the News
During the COVID‑19 pandemic, herd‑immunity calculations sparked intense debate and influenced vaccination strategies across countries. Recent studies highlight that achieving global herd immunity may require coordinated international vaccination efforts and monitoring of emerging variants. The concept continues to drive policy discussions about optimal vaccine coverage thresholds.
